Abstract
The author has updated the Acknowledgment Section of the article published in Current Alzheimer Research Volume 16, No. 3, 2019, pp. 209-218. Inhibition of the PERK-dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer’s Disease
Acknowledgements:
This work was supported by grant PRELUDIUM no. 2015/19/N/NZ3/00055 from the Polish National Science Centre, grant of Medical University of Lodz no. 502-03/5-108-05/502-54-194, grant OPUS no. 2016/21/B/NZ5/01411 from the Polish National Science Centre, grant HARMONIA no. 2013/10/M/NZ1/00280 and grant of Medical University of Lodz, Poland no. 502- 03/5-108-05/502-54-224-18.
Current Alzheimer Research
Title:Inhibition of the PERK-dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer’s Disease
Volume: 16 Issue: 6
Author(s): Wioletta Rozpędek, Dariusz Pytel, Tomasz Popławski, Anna Walczak, Kinga Gradzik and Adam Wawrzynkiewicz
Affiliation:
Abstract:
The author has updated the Acknowledgment Section of the article published in Current Alzheimer Research Volume 16, No. 3, 2019, pp. 209-218. Inhibition of the PERK-dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer’s Disease
Acknowledgements:
This work was supported by grant PRELUDIUM no. 2015/19/N/NZ3/00055 from the Polish National Science Centre, grant of Medical University of Lodz no. 502-03/5-108-05/502-54-194, grant OPUS no. 2016/21/B/NZ5/01411 from the Polish National Science Centre, grant HARMONIA no. 2013/10/M/NZ1/00280 and grant of Medical University of Lodz, Poland no. 502- 03/5-108-05/502-54-224-18.
Export Options
About this article
Cite this article as:
Rozpędek Wioletta , Pytel Dariusz , Popławski Tomasz, Walczak Anna , Gradzik Kinga and Wawrzynkiewicz Adam , Inhibition of the PERK-dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer’s Disease, Current Alzheimer Research 2019; 16 (6) . https://dx.doi.org/10.2174/156720501606190723163906
DOI https://dx.doi.org/10.2174/156720501606190723163906 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Application of Tissue Doppler Imaging in Coronary Artery Diseases and Heart Failure
Recent Patents on Medical Imaging Proteomics for Transthyretin (TTR) Related Amyloidosis
Current Proteomics Tramadol Induced QTc-Interval Prolongation: Prevalence, Clinical Factors and Correlation to Plasma Concentrations
Current Drug Safety Alzheimers Disease: From Pathogenesis to Disease-Modifying Approaches
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: Neurology and Genetics: How Molecular Biology is Changing the Neurological Thoughts?)
Current Molecular Medicine The Role of Melanin to Dissociate Oxygen from Water to Treat Retinopathy of Prematurity
Central Nervous System Agents in Medicinal Chemistry Commentary-2 Research Highlights: (Adult-Born Neurons with Unique GABAergic Synapses)
CNS & Neurological Disorders - Drug Targets The Learning-based Automatic Segmentation Algorithm of Brain MR Images Based on 7T
Current Medical Imaging Proteoglycans and Glycosaminoglycans in Misfolded Proteins Formation in Alzheimer's Disease
Protein & Peptide Letters Amendatory Effect of Flavonoids in Alzheimer's Disease Against Mitochondrial Dysfunction
Current Drug Targets Nanocarriers as Tools in Delivering Active Compounds for Immune System Related Pathologies
Recent Patents on Nanotechnology Spinal Cord Injury Changes Cytokine Transport
CNS & Neurological Disorders - Drug Targets High Fat Intake, Inflammation and Risk of Neuropsychiatric Disorders
Current Immunology Reviews (Discontinued) Pyridinium Oximes as Cholinesterase Reactivators. Structure-Activity Relationship and Efficacy in the Treatment of Poisoning with Organophosphorus Compounds
Current Medicinal Chemistry The Effects of Gender and CYP46 and Apo E Polymorphism on 24S-Hydroxycholesterol Levels in Alzheimers Patients Treated with Statins
Current Alzheimer Research RETRACTED: Human Suicide, Modern Diagnosis Assistance and Magic Bullet Discovery
Central Nervous System Agents in Medicinal Chemistry SUBJECT INDEX TO VOLUME 4 Current Organic Chemistry
Current Organic Chemistry Potassium Channel Blockers and Openers as CNS Neurologic Therapeutic Agents
Recent Patents on CNS Drug Discovery (Discontinued) A Review on Hematopoietic Stem Cell Treatment for Epilepsy
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Ion Channels as Therapeutic Targets for Neuropathic Pain (Executive Editor: Char-Chang Shieh)]
Current Pharmaceutical Design